← Eichor
Study identifier: NCT07627763 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease

Condition: COPD  ·  Sponsor: Initiatives Bronchopneumopathie Chronique Obstructive (BPCO)

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This prospective, multicenter, real-world observational cohort study will describe phenotypic profiles, patient characteristics, and treatments in adults with stable chronic obstructive pulmonary disease (COPD). The profiles observed in the current cohort will be compared with those of patients recruited between 2005 and 2018 in the previous COPD-BPCO 1 cohort. Patients will be followed for at least 3 years as part of routine care, with no study-specific visit or treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Renaud URBINELLI  ·  +33756882093  ·  etudes@clin-experts.fr

José GARCIA-MACE

Always discuss trial participation with your own doctor first.

Locations (7)

Chu BordeauxBordeaux, FranceRecruiting
Chu LilleLille, FranceRecruiting
Chu LilleLille, FranceRecruiting
Chu Nancy-BraboisNancy, FranceRecruiting
Hopital CochinParis, FranceRecruiting
Chu ReimsReims, FranceRecruiting
Chu Saint EtienneSaint-Etienne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07627763